Press Releases & Statements

Investor Relations

Month Year

Month Year

Novavax Appoints Vaccine Industry Expert Margaret G. McGlynn to Board of Directors
- Corporate and Finance
Dec 9, 2020
Novavax Announces COVID-19 Vaccine Clinical Development Progress
- COVID-19
Nov 30, 2020
Novavax to Participate in Upcoming Conferences
- Corporate and Finance
Nov 25, 2020
Novavax to Host Conference Call for Questions Related to Third Quarter Financial and Operating Results on November 10, 2020
- Corporate and Finance
Nov 10, 2020
Novavax COVID-19 Vaccine Granted Fast Track Designation by U.S. FDA
- COVID-19
Nov 9, 2020
Novavax Appoints Gregory F. Covino as Chief Financial Officer and Announces Leadership Updates
- Corporate and Finance
Nov 9, 2020
Novavax Reports Third Quarter 2020 Financial and Operational Results
- Corporate and Finance
Nov 9, 2020
Novavax and Commonwealth of Australia Announce Agreement in Principle for Acquisition of Novavax COVID-19 Vaccine
- COVID-19
Nov 4, 2020
Novavax to Host Conference Call to Discuss Third Quarter Financial and Operating Results on November 9, 2020
- Corporate and Finance
Nov 3, 2020
Novavax Appoints Biopharmaceutical Industry Veteran Gregg Alton to Board of Directors
- Corporate and Finance
Nov 3, 2020

Show per page